GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Viking Therapeutics's Options: A Look at What the Big Money Is Thinking
Novo Nordisk Unusual Options Activity For July 26
Catalyst Watch: Tech Blitz With Apple, Amazon, Microsoft, and Meta on Tap for Earnings
FDA Issues Warning on Compounded Versions of Novo Nordisk's Semaglutide
10 Health Care Stocks Whale Activity In Today's Session
Sangamo Rallies for Third Day in Wake of Positive Gene Therapy Results